在COVID-19中增加血栓形成风险:证据和争议
Antonio De Vita1, Francesco Franceschi2, Marcello Covino2
1Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168 Roma, Italy.
Journal of clinical medicine
|July 14, 2023
概括
目前正在进行的流行病是由SARS-CoV-2引起的,它是一种新型冠状病毒. 这项研究解决了这种呼吸系统疾病所带来的持续的全球健康挑战.
科学领域:
- * 病毒学和流行病学
- * 传染病 传染病
- * * 公共卫生 公共卫生
背景情况:
- *2019年底SARS-CoV-2的出现引发了全球大流行.
- *由此引起的呼吸系统疾病COVID-19继续在全球范围内构成重大公共卫生威胁.
- *了解SARS-CoV-2的持续影响和特征对于有效管理至关重要.
研究的目的:
- *分析SARS-CoV-2流行病的持续影响.
- * 提供有关新型冠状病毒疾病流行病学的见解.
- *为正在进行的公共卫生战略提供信息,以应对呼吸系统疾病.
主要方法:
- * [具体方法将在这里详细介绍,例如流行病学数据分析,临床病例审查,基因组测序等]
- * [方法专注于追踪疾病传播和影响.]
- * [使用的数据来源和分析方法.]
主要成果:
- * [关于疾病患病率,传播或严重程度的关键发现将在这里介绍.]
- * [与研究目标相关的具体结果.]
- * [支持结论的可量化的数据.]
结论:
- *SARS-CoV-2流行病仍然是一个活跃的全球健康问题.
- *持续的研究和监测对于控制新型冠状病毒的传播至关重要.
- * 需要有效的公共卫生干预措施来减轻呼吸系统疾病的持续影响.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
763
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
763
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Venous Thrombosis I: Introduction
13
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
13
Factors Affecting the Risk of Infection
12.0K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.0K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
14
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
14


